On 2025-05-08, Organogenesis (ORGO) announced earnings per share of $-0.13 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $0.04.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.10 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $0.04 | $-0.13 |
| 2025-02-27 | 2024-12-31 | $-0.03 | $0.04 |
| 2024-11-12 | 2024-09-30 | $-0.02 | $0.09 |
| 2024-08-08 | 2024-06-30 | $-0.02 | $-0.13 |
| 2024-05-09 | 2024-03-31 | $-0.03 | $-0.02 |
| 2024-02-29 | 2023-12-31 | $-0.01 | $0.00 |
| 2023-11-09 | 2023-09-30 | $0.01 | $0.02 |
| 2023-08-09 | 2023-06-30 | $0.02 | $0.04 |
| 2023-05-10 | 2023-03-31 | -- | $-0.02 |
| 2023-03-01 | 2022-12-31 | -- | $0.06 |
| 2022-11-09 | 2022-09-30 | $0.06 | $0.04 |
| 2022-08-09 | 2022-06-30 | $0.08 | $0.09 |
| 2022-05-10 | 2022-03-31 | $0.05 | $0.01 |
| 2022-03-01 | 2021-12-31 | $0.08 | $0.41 |
| 2021-11-09 | 2021-09-30 | $0.06 | $0.09 |
| 2021-08-09 | 2021-06-30 | $0.07 | $0.15 |
| 2021-05-10 | 2021-03-31 | $-0.04 | $0.07 |
| 2021-03-16 | 2020-12-31 | $0.12 | $0.15 |
| 2020-11-09 | 2020-09-30 | $-0.07 | $0.19 |
| 2020-08-10 | 2020-06-30 | $-0.12 | $-0.05 |
| 2020-05-11 | 2020-03-31 | $-0.12 | $-0.16 |
| 2020-03-09 | 2019-12-31 | $-0.10 | $-0.04 |
| 2019-11-12 | 2019-09-30 | $-0.13 | $-0.12 |
| 2019-08-09 | 2019-06-30 | $-0.13 | $-0.11 |
| 2019-05-10 | 2019-03-31 | $-0.10 | $-0.15 |